Impact of 6‐ versus 12‐month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4‐year results of the I LOVE IT 2 study

Volume: 97, Issue: S2, Pages: 1025 - 1031
Published: Mar 1, 2021
Abstract
To explore the impact of 6- versus 12-month dual antiplatelet therapy (DAPT) on the clinical prognosis of high bleeding risk (HBR) patients.The optimal DAPT duration after percutaneous coronary intervention (PCI) in HBR patients is unclear.This study is a post hoc analysis of the 4-year clinical follow-up results of the I LOVE IT 2 study. Prevalence and prognosis of HBR patients were explored, and clinical outcomes of HBR patients who underwent...
Paper Details
Title
Impact of 6‐ versus 12‐month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4‐year results of the I LOVE IT 2 study
Published Date
Mar 1, 2021
Volume
97
Issue
S2
Pages
1025 - 1031
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.